CD80 and focal segmental glomerulosclerosis: In addition, positive staining of CD80 in renal specimens of both relapse MCD and FSGS further indicates a possible pathogenesis of podocyte CD80 in INS, and it is utilized as a biomarker to identify patients who may benefit from abatacept [5, 6, 15].